Global Pharmaceutical Testing and Analytical Services Market Size, Share, Trends & Growth Analysis Report 2026-2034

Description

The Pharmaceutical Testing and Analytical Services Market size is expected to reach USD 18.35 Billion in 2034 from USD 8.60 Billion (2025) growing at a CAGR of 8.78% during 2026-2034.

The Global Pharmaceutical Testing and Analytical Services Market is growing steadily due to increasing drug development activities and stringent regulatory requirements. Pharmaceutical companies rely on specialized analytical services to ensure product safety, quality, and compliance. The rise in complex biologics and biosimilars has further boosted demand for advanced analytical testing solutions.

Key drivers include expanding clinical trials, outsourcing trends among pharmaceutical companies, and rising regulatory scrutiny. Contract research organizations are investing in sophisticated instrumentation and skilled professionals to deliver accurate results. Growing focus on quality assurance and stability testing is also fueling consistent demand across global markets.

Looking forward, the market is expected to benefit from continuous growth in the pharmaceutical and biotechnology sectors. Increased R&D investments and the development of novel therapies will sustain demand for analytical expertise. Emerging economies offer significant opportunities due to expanding manufacturing facilities. Overall, technological advancements and regulatory compliance requirements will drive long-term growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type of Testing

Analytical Testing
Bioanalytical Testing
Stability Testing
Microbiological Testing
Method Development And Validation

By Service Type

Contract Research Organizations (CROs)
In-house Testing Laboratories
Third-Party Testing Laboratories
Regulatory Compliance Services

By Drug Type

Small Molecule
Biologics
Generics
OTC Drugs

By End-User

Pharmaceutical Companies
Biotechnology Firms
Academic And Research Institutes
Contract Manufacturing Organizations (CMOs)

By Geography of Services

Preclinical Testing Services
Clinical Testing Services
Post-Market Surveillance Services
Regulatory Affairs Services

COMPANIES PROFILED

Eurofins Scientific SE, SGS, Envigo, Exova Group PLC, PPD Inc, Pace Analytical Services Inc, Intertek Group, DYNALABS, RD Laboratories, EAG Inc, ADPEN Laboratories, West Pharmaceutical Services Inc, Polymer Solutions, Boston Analytical
We can customise the report as per your requirements.

Product Code: VMR112114194

Chapter 1. PREFACE

1.1. Market Segmentation & Scope
1.2. Market Definition
1.3. Information Procurement
- 1.3.1 Information Analysis
- 1.3.2 Market Formulation & Data Visualization
- 1.3.3 Data Validation & Publishing
1.4. Research Scope and Assumptions
- 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

2.1. Market Snapshot
2.2. Segmental Outlook
2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

3.1. Market Lineage Outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Value Chain Analysis
3.4. Regulatory Framework
- 3.4.1 Standards & Compliance
- 3.4.2 Regulatory Impact Analysis
3.5. Market Dynamics
- 3.5.1 Market Drivers
- 3.5.2 Market Restraints
- 3.5.3 Market Opportunities
- 3.5.4 Market Challenges
3.6. Porter's Five Forces Analysis
3.7. PESTLE Analysis

Chapter 4. GLOBAL PHARMACEUTICAL TESTING AND ANALYTICAL SERVICES MARKET: BY TYPE OF TESTING 2022-2034 (USD MN)

4.1. Market Analysis, Insights and Forecast Type Of Testing
4.2. Analytical Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
4.3. Bioanalytical Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
4.4. Stability Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
4.5. Microbiological Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
4.6. Method Development And Validation Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL PHARMACEUTICAL TESTING AND ANALYTICAL SERVICES MARKET: BY SERVICE TYPE 2022-2034 (USD MN)

5.1. Market Analysis, Insights and Forecast Service Type
5.2. Contract Research Organizations (CROs) Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.3. In-house Testing Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.4. Third-Party Testing Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.5. Regulatory Compliance Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL PHARMACEUTICAL TESTING AND ANALYTICAL SERVICES MARKET: BY DRUG TYPE 2022-2034 (USD MN)

6.1. Market Analysis, Insights and Forecast Drug Type
6.2. Small Molecule Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.3. Biologics Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.4. Generics Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.5. OTC Drugs Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL PHARMACEUTICAL TESTING AND ANALYTICAL SERVICES MARKET: BY END-USER 2022-2034 (USD MN)

7.1. Market Analysis, Insights and Forecast End-user
7.2. Pharmaceutical Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
7.3. Biotechnology Firms Estimates and Forecasts By Regions 2022-2034 (USD MN)
7.4. Academic And Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
7.5. Contract Manufacturing Organizations (CMOs) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL PHARMACEUTICAL TESTING AND ANALYTICAL SERVICES MARKET: BY GEOGRAPHY OF SERVICES 2022-2034 (USD MN)

8.1. Market Analysis, Insights and Forecast Geography Of Services
8.2. Preclinical Testing Services Estimates and Forecasts By Regions 2022-2034 (USD MN)
8.3. Clinical Testing Services Estimates and Forecasts By Regions 2022-2034 (USD MN)
8.4. Post-Market Surveillance Services Estimates and Forecasts By Regions 2022-2034 (USD MN)
8.5. Regulatory Affairs Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL PHARMACEUTICAL TESTING AND ANALYTICAL SERVICES MARKET: BY REGION 2022-2034(USD MN)

9.1. Regional Outlook
9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 9.2.1 By Type Of Testing
- 9.2.2 By Service Type
- 9.2.3 By Drug Type
- 9.2.4 By End-user
- 9.2.5 By Geography Of Services
- 9.2.6 United States
- 9.2.7 Canada
- 9.2.8 Mexico
9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 9.3.1 By Type Of Testing
- 9.3.2 By Service Type
- 9.3.3 By Drug Type
- 9.3.4 By End-user
- 9.3.5 By Geography Of Services
- 9.3.6 United Kingdom
- 9.3.7 France
- 9.3.8 Germany
- 9.3.9 Italy
- 9.3.10 Russia
- 9.3.11 Rest Of Europe
9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 9.4.1 By Type Of Testing
- 9.4.2 By Service Type
- 9.4.3 By Drug Type
- 9.4.4 By End-user
- 9.4.5 By Geography Of Services
- 9.4.6 India
- 9.4.7 Japan
- 9.4.8 South Korea
- 9.4.9 Australia
- 9.4.10 South East Asia
- 9.4.11 Rest Of Asia Pacific
9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 9.5.1 By Type Of Testing
- 9.5.2 By Service Type
- 9.5.3 By Drug Type
- 9.5.4 By End-user
- 9.5.5 By Geography Of Services
- 9.5.6 Brazil
- 9.5.7 Argentina
- 9.5.8 Peru
- 9.5.9 Chile
- 9.5.10 South East Asia
- 9.5.11 Rest of Latin America
9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 9.6.1 By Type Of Testing
- 9.6.2 By Service Type
- 9.6.3 By Drug Type
- 9.6.4 By End-user
- 9.6.5 By Geography Of Services
- 9.6.6 Saudi Arabia
- 9.6.7 UAE
- 9.6.8 Israel
- 9.6.9 South Africa
- 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

10.1. Recent Developments
10.2. Company Categorization
10.3. Supply Chain & Channel Partners (based on availability)
10.4. Market Share & Positioning Analysis (based on availability)
10.5. Vendor Landscape (based on availability)
10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL PHARMACEUTICAL TESTING AND ANALYTICAL SERVICES INDUSTRY

11.1. Top Companies Market Share Analysis
11.2. Company Profiles
- 11.2.1 Eurofins Scientific SE
- 11.2.2 SGS
- 11.2.3 Envigo
- 11.2.4 Exova Group PLC
- 11.2.5 PPD Inc
- 11.2.6 Pace Analytical Services Inc
- 11.2.7 Intertek Group
- 11.2.8 DYNALABS
- 11.2.9 RD Laboratories
- 11.2.10 EAG Inc
- 11.2.11 ADPEN Laboratories
- 11.2.12 West Pharmaceutical Services Inc
- 11.2.13 Polymer Solutions
- 11.2.14 Boston Analytical